10.2165/00002018-199920020-00002 6 ButlerA
All Ingredients: Water, Dipropylene Glycol, Tripropylene Glycol, Cellulose, Butylene Glycol, Propanediol, Carbomer, Steartrimonium Methosulfate, 1,2-Hexanediol, Glycerin, Saccharide Isomerate, Isopropyl Alcohol, Hydroxyacetophenone, Coptis Japonica Root Extract, Glycereth-25 PCA Isostearate, Cetyl Ethylhexanoate, Ethylhexyl Palmitate, Squalane, Sucrose Distearate, Ethylhexylglycerin, Caprylic/Capric Triglyceride, Hydrolyzed Gardenia Florida Extract, Hydrolyzed Malt Extract, Hydrolyzed Viola Tricolor Extract, Fragrance, Disodium EDTA, Hydrogenated Lecithin, Hyaluronic Acid, Hydrolyzed Hyaluronic Acid, Sodium Hyaluronate, Curcuma Longa (Turmeric) Root Extract, Kojic Acid, Niacinamide, Panthenol, Glycolic Acid, Citric Acid, Sodium Citrate, Theobroma Cacao (Cocoa) Seed Extract, Dextrin, CI 17200, Ascorbic Acid, Centella Asiatica Extract, Gluconolactone
[63] It declared the shortage over in October 2024, but enforcement was delayed until the end of 2024, after a lawsuit by compounding pharmacies challenged the declaration
Antioxidant & Toxin Support: Glutathione helps protect liver cells from oxidative stress and supports removal of everyday toxins
In the treatment of AD, microneedles loaded with epigallocatechin gallate, a potent antioxidant, and L-ascorbic acid as a stabilizing reductant, prepared from poly--glutamic acid, exhibit multiple beneficial functions
Regulatory Status and FDA Approval Timeline Current FDA Status (as of June 2026) The FDA has not approved retatrutide for any indication as of June 2026
